OpGen, Inc. (OTC:OPGN – Get Free Report) shares crossed above its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $19.38 and traded as high as $31.75. OpGen shares last traded at $31.75, with a volume of 698 shares trading hands.
OpGen Stock Performance
The stock has a fifty day simple moving average of $19.38 and a two-hundred day simple moving average of $8.73. The stock has a market cap of $319.75 million, a price-to-earnings ratio of -5.70 and a beta of -1.77.
OpGen Company Profile
OpGen, Inc (NASDAQ: OPGN) is a precision medicine company specializing in molecular diagnostics and digital solutions for infectious disease management. Leveraging next-generation sequencing, bioinformatics and molecular assay technologies, OpGen develops tools designed to detect microbial pathogens and antimicrobial resistance markers rapidly and accurately. The company’s mission is to support clinicians and laboratories in making timely, informed treatment decisions that help curb the spread of drug-resistant infections.
Among OpGen’s key offerings is the Acuitas® AMR Gene Panel, a suite of molecular assays that identify genetic determinants of antibiotic resistance directly from positive blood cultures.
Read More
- Five stocks we like better than OpGen
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- Unlocked: Elon Musk’s Next Big IPO
- My Epstein Story
- This $15 Stock Could Go Down as the #1 Stock of 2026
- What a Former CIA Agent Knows About the Coming Collapse
Receive News & Ratings for OpGen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OpGen and related companies with MarketBeat.com's FREE daily email newsletter.
